Patient characteristics in the randomisation groups
| All patients | Patients with EQ-5D utility scores at baseline and at 6-month follow-up | |||
| Intervention (n=164) | Control (n=181) | Intervention (n=116) | Control (n=124) | |
| Age, years | 81 (72–87) | 82 (75–86) | 82 (72–87) | 82 (76–85) |
| Female sex | 98 (60) | 110 (61) | 71 (61) | 78 (63) |
| Length of stay in hospital, days | 6 (4–10) | 6 (4–10.5) | 7 (5–10.75) | 6.5 (4–11) |
| Regularly prescribed drugs at admission, n | 7 (4–9) | 7 (4–10) | 7 (4–10) | 7.5 (4.25–10) |
| Prescribed drugs as needed at admission, n | 1 (0–2) | 1 (0–3) | 1 (0–2) | 1 (0–3) |
Values are presented as median (IQR) or n (%).
EQ-5D, EuroQol-5 dimensions.